SCHEMBL8034875

SCHEMBL8034875

CCOC(=O)CNC(=O)CCCCCNC(=O)c1ccco1

nearest known ligand 0.61

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.61
SMN1; SMN2 Q16637 3/20 0.61
PKM P14618 1/20 0.61
GAA P10253 1/20 0.57
HDAC3 O15379 1/20 0.55
HDAC1 Q13547 1/20 0.55
CYP1A2 P05177 1/20 0.52
CYP3A4 P08684 1/20 0.52
APEX1 P27695 1/20 0.52
CYP2C19 P33261 1/20 0.52
TSHR P16473 2/20 0.50
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
POLB P06746 1/20 0.50
KDM4E B2RXH2 1/20 0.50
LMNA P02545 1/20 0.47
RAB9A P51151 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12882119 0.84 ALDH1A1 (0.65) ALDH1A1SMN1; SMN2PKMGAACYP1A2
SCHEMBL8029037 0.81 GAA (0.62) ALDH1A1SMN1; SMN2GAAHDAC3HDAC1
SCHEMBL24653230 0.80 SMN1; SMN2 (0.75) ALDH1A1SMN1; SMN2PKMHDAC3HDAC1
SCHEMBL1232799 0.80 SMN1; SMN2 (0.75) ALDH1A1SMN1; SMN2PKMHDAC3HDAC1
SCHEMBL8030811 0.80 GAA (0.61) ALDH1A1GAAHDAC3HDAC1CYP3A4
SCHEMBL1233157 0.79 SMN1; SMN2 (0.77) ALDH1A1SMN1; SMN2PKMHDAC3HDAC1
SCHEMBL16266236 0.78 SMN1; SMN2 (1.00) ALDH1A1SMN1; SMN2PKMHDAC3HDAC1
SCHEMBL9784444 0.77 SMN1; SMN2 (0.84) ALDH1A1SMN1; SMN2PKMGAAHDAC3
SCHEMBL2719119 0.77 SMN1; SMN2 (0.84) ALDH1A1SMN1; SMN2PKMGAAHDAC3
SCHEMBL15999997 0.77 SMN1; SMN2 (0.84) ALDH1A1SMN1; SMN2PKMGAAHDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0797579-B1 ERYTHROMYCIN A 9-0-OXIME DERIVATIVES ENDOWED WITH ANTIBIOTIC ACTIVITY ZAMBON SPA (IT) 2000-03-15 EP disclosed
CN-1046535-C Erythromycin A 9-0-oxime derivatives endowed with antibiotic activity ZAMBON SPA (IT) 1999-11-17 CN disclosed
US-5847092-A Erythromycin A 9-0 oxime derivatives endowed with antibiotic activity ZAMBON GROUP S.P.A. (IT) 1998-12-08 US disclosed
CN-1169727-A Erythromycin A 9-0-oxime derivatives endowed with antibiotic activity ZAMBON SPA (IT) 1998-01-07 CN disclosed
EP-0797579-A1 ERYTHROMYCIN A 9-0-OXIME DERIVATIVES ENDOWED WITH ANTIBIOTIC ACTIVITY ZAMBON GROUP S.p.A. (IT) 1997-10-01 EP disclosed
WO-1996018633-A1 ERYTHROMYCIN A 9-0-OXIME DERIVATIVES ENDOWED WITH ANTIBIOTIC ACTIVITY ZAMBON GROUP S.P.A. (IT) 1996-06-20 WO disclosed